Health IT
Working Out the Kinks in Health IT
Industry execs and gov't officials convened in Washington DC yesterday to discuss the present and future state of health IT, and to identify the bugs, challenges and hiccups that continue to plague technology platforms and the policies that regulate them
...Read more
Advertisement
Statistical methodologies will help you capture and use drug experience data to generate meaningful inferences from pooled and observational data. This paper focuses on one such premier methodology, meta-analysis. We illustrate the application of the traditional methods of meta-analysis and also the more recent Bayesian approach to meta-analysis in the context of RAA (renin-angiotensin-aldosterone) system blockers/antagonists.
 www.Sciformix.com/smartstudy.php |
Leadership
Measuring Responsibility in Big Pharma
If you can't measure it, the saying goes, it doesn't count. But what if you're measuring the wrong things? Peter Pitts takes issue with the Access to Medicines Index, the latest version of which is slated for an October release
...Read More
Regulatory
Value-Based Pricing: The Queen's English
The United Kingdom has always set the precedent on pharmaceutical drug pricing. With the proposal of a new value-based pricing system, which would replace the tried and true Pharmaceutical Price Regulation Scheme, Big Pharma in Britain – and the rest of the world – is taking notice ...Read More
Advertisement
2nd Annual Interactive Response Technologies for Clinical Trials
November 8-9, 2012 * Sonesta Hotel * Philadelphia, PA
Learn best practices in gaining insights into IVR/IWR system utilization in clinical trials and learn how companies are using clinical IRTs to increase efficiencies and decrease costs. Register by November 7, 2012 at  www.cbinet.com/IRT and save $400 with priority code: FHZ888 |
Global
Japanese Pharma Market Makes a Comeback
After a series of government reforms that appeal to both domestic and foreign players, the Japanese pharmaceutical market is making a comeback
...Read more
Advertisement
2nd Global Transparency Reporting Congress—17-18 October, 2012 Amsterdam, Netherlands
Implement Business Processes to Manage and Report HCP Spend Data. Attend the premier Transparency Reporting event of the year and hear best practices for tracking and disclosing data, controlling spend on HCPs, implementing efficient systems and aligning goals across the company from EFPIA, Sanofi, Johnson & Johnson and more! Register by 16 October, 2012 at  www.cbinet.com/transparency and save €300 with priority code: KDZ968.
|
|
